Publication

Epidermal Growth Factor Promotes Protein Degradation of Epithelial Protein Lost in Neoplasm (EPLIN), a Putative Metastasis Suppressor, during Epithelial-mesenchymal Transition

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Shumin Zhang, Emory UniversityXu Wang, Emory UniversityShareen Iqbal, Emory UniversityYanru Wang, Emory UniversityAdeboye O. Osunkoya, Emory UniversityZhengjia Chen, Emory UniversityZhuo Chen, Emory UniversityDong M Shin, Emory UniversityHongwei Yuan, Inner Mongolia Medical CollegeYongqiang A. Wang, Ocean NanoTech, LLCHaiyen E. Zhau, Cedars-Sinai Medical CenterLeland W. K. Chung, Cedars-Sinai Medical CenterChad Ritenour, Emory UniversityOmer Kucuk, Emory UniversityDaqing Wu, Emory University
Language
  • English
Date
  • 2013-01-18
Publisher
  • American Society for Biochemistry and Molecular Biology
Publication Version
Copyright Statement
  • © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 288
Issue
  • 3
Start Page
  • 1469
End Page
  • 1479
Grant/Funding Information
  • This work was also supported by American Cancer Society Grant RSG-10-140-01 (to D. W.).
  • This work was supported, in whole or in part, by NCI, National Institutes of Health Grants 1R21CA164612-01A1 (to D. W), 1R43CA141870 (to Y. A. W), P01 CA098912 and R01 CA122602 (to L. W. K. C), and Georgia Cancer Coalition Distinguished Scholar Grant (to O. K).
Abstract
  • Background: The mechanism of EGF signaling in the regulation of prostate cancer (PCa) metastasis remains unclear. Results: EGF promotes epithelial-mesenchymal transition (EMT) and induces degradation of epithelial protein lost in neoplasm (EPLIN), a putative suppressor of PCa metastasis. Conclusion: EGF activates ERK1/2-dependent phosphorylation, ubiquitination, and protein turnover of EPLIN. Significance: This study suggested that blockade of EGF signaling could retard EMT and inhibit invasiveness of PCa cells.
Author Notes
  • To whom correspondence should be addressed: Dept. of Urology, Emory University School of Medicine, 1365 Clifton Rd., NE., Clinic B, B5107, Atlanta, GA 30322. Tel.: 404-778-4845; E-mail: dwu2@emory.edu.
Keywords
Research Categories
  • Health Sciences, Oncology
  • Chemistry, Biochemistry

Tools

Relations

In Collection:

Items